HEB - Hemispherx Biopharma, Inc.

NYSE American - Nasdaq Real Time Price. Currency in USD
Show:

Balance Sheet

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Current Assets
Cash And Cash Equivalents2991,4122,4082,115
Short Term Investments1,5266953,4606,795
Net Receivables1,09424--
Inventory---1,326
Other Current Assets-764764-
Total Current Assets3,7993,5056,94110,571
Long Term Investments----
Property, plant and equipment7,7828,5869,51411,237
Goodwill----
Intangible Assets912858872862
Accumulated Amortization----
Other Assets1,3521,2581,546134
Deferred Long Term Asset Charges----
Total Assets13,84514,20718,87322,804
Current Liabilities
Accounts Payable6807418871,213
Short/Current Long Term Debt----
Other Current Liabilities----
Total Current Liabilities5,2922,7072,4352,433
Long Term Debt-1,835--
Other Liabilities1,061962940-
Deferred Long Term Liability Charges----
Minority Interest----
Negative Goodwill----
Total Liabilities8,6715,5043,3752,433
Stockholders' Equity
Misc. Stocks Options Warrants----
Redeemable Preferred Stock----
Preferred Stock----
Common Stock49332421
Retained Earnings-318,573-308,760-300,501-292,999
Treasury Stock-311-5-97
Capital Surplus323,701317,419315,980313,446
Other Stockholder Equity-311-5-97
Total stockholders' equity5,1748,70315,49820,371
Net Tangible Assets4,2627,84514,62619,509